OPTISENSE Trademark

Trademark Overview

On Friday, February 28, 2025, a trademark application was filed for OPTISENSE with the United States Patent and Trademark Office. The USPTO has given the OPTISENSE trademark a serial number of 79420475. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, August 1, 2025. This trademark is owned by Compass HealthAI Applications Inc.. The OPTISENSE trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus, namely, a handheld Raman spectrometer for measuring macular pigment optical density (MPOD) and providing personalized dietary and supplementation recommendations.
optisense

General Information

Serial Number79420475
Word MarkOPTISENSE
Filing DateFriday, February 28, 2025
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateFriday, August 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkOPTI SENSE
Goods and ServicesMedical apparatus, namely, a handheld Raman spectrometer for measuring macular pigment optical density (MPOD) and providing personalized dietary and supplementation recommendations.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCompass HealthAI Applications Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCA

Trademark Events

Event DateEvent Description
Thursday, April 3, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 1, 2025ASSIGNED TO EXAMINER
Friday, April 4, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

optisense providing mpod density personalized dietary recommendations supplementation optical pigment handheld